153 related articles for article (PubMed ID: 16810312)
21. p53 immunostaining suggests that uterine carcinosarcomas are monoclonal.
Mayall F; Rutty K; Campbell F; Goddard H
Histopathology; 1994 Mar; 24(3):211-4. PubMed ID: 8200622
[TBL] [Abstract][Full Text] [Related]
22. Reduced COX-2 protein in colorectal cancer with defective mismatch repair.
Karnes WE; Shattuck-Brandt R; Burgart LJ; DuBois RN; Tester DJ; Cunningham JM; Kim CY; McDonnell SK; Schaid DJ; Thibodeau SN
Cancer Res; 1998 Dec; 58(23):5473-7. PubMed ID: 9850081
[TBL] [Abstract][Full Text] [Related]
23. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
[TBL] [Abstract][Full Text] [Related]
24. Defects of DNA mismatch repair in human prostate cancer.
Chen Y; Wang J; Fraig MM; Metcalf J; Turner WR; Bissada NK; Watson DK; Schweinfest CW
Cancer Res; 2001 May; 61(10):4112-21. PubMed ID: 11358834
[TBL] [Abstract][Full Text] [Related]
25. Microsatellite instability and expression of DNA mismatch repair genes in malignant astrocytic tumors from adult and pediatric patients.
Szybka M; Bartkowiak J; Zakrzewski K; Polis L; Liberski P; Kordek R
Clin Neuropathol; 2003; 22(4):180-6. PubMed ID: 12908754
[TBL] [Abstract][Full Text] [Related]
26. Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component.
de Jong RA; Nijman HW; Wijbrandi TF; Reyners AK; Boezen HM; Hollema H
Mod Pathol; 2011 Oct; 24(10):1368-79. PubMed ID: 21572397
[TBL] [Abstract][Full Text] [Related]
27. Defective mismatch-repair as a minor tumorigenic pathway in Barrett esophagus-associated adenocarcinoma.
Falkenback D; Johansson J; Halvarsson B; Nilbert M
Cancer Genet Cytogenet; 2005 Feb; 157(1):82-6. PubMed ID: 15676154
[TBL] [Abstract][Full Text] [Related]
28. Molecular variations in uterine carcinosarcomas identify therapeutic opportunities.
Crane E; Naumann W; Tait D; Higgins R; Herzog T; Brown J
Int J Gynecol Cancer; 2020 Apr; 30(4):480-484. PubMed ID: 32114514
[TBL] [Abstract][Full Text] [Related]
29. Heterogenous mismatch-repair status in colorectal cancer.
Joost P; Veurink N; Holck S; Klarskov L; Bojesen A; Harbo M; Baldetorp B; Rambech E; Nilbert M
Diagn Pathol; 2014 Jun; 9():126. PubMed ID: 24968821
[TBL] [Abstract][Full Text] [Related]
30. Microsatellite instability in esophageal adenocarcinoma.
Evans SC; Gillis A; Geldenhuys L; Vaninetti NM; Malatjalian DA; Porter GA; Guernsey DL; Casson AG
Cancer Lett; 2004 Aug; 212(2):241-51. PubMed ID: 15279904
[TBL] [Abstract][Full Text] [Related]
31. Germline and somatic mutation analyses in the DNA mismatch repair gene MLH3: Evidence for somatic mutation in colorectal cancers.
Lipkin SM; Wang V; Stoler DL; Anderson GR; Kirsch I; Hadley D; Lynch HT; Collins FS
Hum Mutat; 2001 May; 17(5):389-96. PubMed ID: 11317354
[TBL] [Abstract][Full Text] [Related]
32. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.
Chen Y; Wang J; Fraig MM; Henderson K; Bissada NK; Watson DK; Schweinfest CW
Int J Oncol; 2003 May; 22(5):1033-43. PubMed ID: 12684669
[TBL] [Abstract][Full Text] [Related]
33. Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine.
Planck M; Ericson K; Piotrowska Z; Halvarsson B; Rambech E; Nilbert M
Cancer; 2003 Mar; 97(6):1551-7. PubMed ID: 12627520
[TBL] [Abstract][Full Text] [Related]
34. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis.
Berends MJ; Wu Y; Sijmons RH; van der Sluis T; Ek WB; Ligtenberg MJ; Arts NJ; ten Hoor KA; Kleibeuker JH; de Vries EG; Mourits MJ; Hollema H; Buys CH; Hofstra RM; van der Zee AG
J Clin Oncol; 2003 Dec; 21(23):4364-70. PubMed ID: 14645426
[TBL] [Abstract][Full Text] [Related]
35. Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients.
Sinicrope FA; Rego RL; Halling KC; Foster N; Sargent DJ; La Plant B; French AJ; Laurie JA; Goldberg RM; Thibodeau SN; Witzig TE
Gastroenterology; 2006 Sep; 131(3):729-37. PubMed ID: 16952542
[TBL] [Abstract][Full Text] [Related]
36. MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers.
Simpkins SB; Bocker T; Swisher EM; Mutch DG; Gersell DJ; Kovatich AJ; Palazzo JP; Fishel R; Goodfellow PJ
Hum Mol Genet; 1999 Apr; 8(4):661-6. PubMed ID: 10072435
[TBL] [Abstract][Full Text] [Related]
37. Colorectal cancer without high microsatellite instability and chromosomal instability--an alternative genetic pathway to human colorectal cancer.
Tang R; Changchien CR; Wu MC; Fan CW; Liu KW; Chen JS; Chien HT; Hsieh LL
Carcinogenesis; 2004 May; 25(5):841-6. PubMed ID: 14729584
[TBL] [Abstract][Full Text] [Related]
38. DNA mismatch repair and the significance of a sebaceous skin tumor for visceral cancer prevention.
Kruse R; Ruzicka T
Trends Mol Med; 2004 Mar; 10(3):136-41. PubMed ID: 15102357
[TBL] [Abstract][Full Text] [Related]
39. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
[TBL] [Abstract][Full Text] [Related]
40. Tissue expression of MLH1, PMS2, MSH2, and MSH6 proteins and prognostic value of microsatellite instability in Wilms tumor: experience of 45 cases.
Diniz G; Aktas S; Cubuk C; Ortac R; Vergin C; Olgun N
Pediatr Hematol Oncol; 2013 May; 30(4):273-84. PubMed ID: 23570624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
